Dear Patients and Families,
Welcome to the UNC bleeding disorders, HHT and thrombosis program’s website. We hope you find this information useful in answering questions and learning about our center.
I am privileged to lead an innovative and dedicated group of professionals who are committed to enhancing the health and quality of life of people with bleeding and clotting disorders through comprehensive health care services, education, and research. Throughout its long history, the UNC Hemophilia and Thrombosis Center has been the core of ground-breaking research achievements and clinical care to benefit patients and their families.
We are happy to be back in clinic and are encouraging in-person visits. We look forward to seeing you, and as always, please contact us at the phone numbers below.
We want you all to be safe and we are here for you.
Sincerely,
Nigel Key, MD
Our News
-
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer’s gene therapy for hemophilia B on Friday, the second such therapy for the rare bleeding disorder that typically requires regular infusions of a blood-clotting protein. Quick article for more information!
-
Shining a Spotlight on Living with Hemophilia
Shining a Spotlight on Living with Hemophilia by our very own Dr. Nigel Key!!
-
2024 Camp Carefree Applications live!! July 21-26, 2024
Parents of campers, head to www.CampCarefree.org/campers for a link to the application forms. Counselors & CITs candidates go here: www.CampCarefree.org/volunteer Note: Covid restrictions have been lifted this year, however vaccines are still STRONGLY recommended. And very IMPORTANT: everyone must ALSO complete and submit the required medical information forms, before you will be considered applied for … Read more
-
Follow Us